🔗 Share this article Patients Coming Off Slimming Medications Regain Pounds Far More Rapidly Than Those on Conventional Diets Weight management involves ongoing approaches. A recent study indicates that patients who discontinue popular GLP-1 drugs like Mounjaro or Wegovy may regain lost weight far faster than those who end conventional lifestyle plans. Research printed in a prominent health publication points out that while overweight individuals can lose a large proportion of their total mass while undergoing treatment, the mass is regained at an average rate of nearly a kilo each month after stopping. "Individuals using such medications should be informed of the potential of rapid rebound weight gain when the therapy ends," cautioned researcher Dr. Susan Jebb. That rate of recovery suggests a return to pre-treatment mass in about 18 months. Analyzing Approaches The analysis, which looked at 37 of studies involving over 9,000 of patients, contrasted the results of the injectable medications with conventional dieting. Researchers emphasize that individuals who shed pounds through diet and exercise generally experience a slower creep back—around 0.1 kg a month—once they finish. Explaining the Rapid Regain Doctors propose the mechanism of the injections accounts for the heightened regain. The injections imitate a body's own chemical called GLP-1, which moderates hunger. "Artificially providing the hormone concentrations far above than normal might result in the system to generate a reduced amount of its own natural hormone, and may also diminish responsiveness to its effects," said Dr. Adam Collins, a nutrition specialist. "Withdrawal of this medication leads to hunger is uncontrolled, making overeating much more probable." An Ongoing Issue? Medical guidelines suggest the injections for people with weight-linked health risks, alongside prescribed diet and exercise modifications. Many experts say that, given the significant potential of relapse, the treatment might need to be long-term. This view is reinforced by drug manufacturers, who say that the findings "underscore the persistent nature of excess weight," akin to managing diseases like diabetes. User Accounts People who have discontinued the medication explain a sudden resurgence of cravings. "It felt as if something flipping and I was suddenly starving," recalled a patient. The struggle is exacerbated if users have not adopted permanent lifestyle or habit changes during therapy. Significant Adoption Figures indicate that millions of people in the UK have tried these injections in the last 12 months, with demand being substantial. Use is higher among females compared to males. The middle-aged demographic shows the highest usage rates. Many access the medications through private prescriptions rather than the NHS. In conclusion, experts emphasize that while these medications are powerful agents for shedding pounds, they are not a permanent solution and maintained weight loss hinges on integrated lifestyle management.
Weight management involves ongoing approaches. A recent study indicates that patients who discontinue popular GLP-1 drugs like Mounjaro or Wegovy may regain lost weight far faster than those who end conventional lifestyle plans. Research printed in a prominent health publication points out that while overweight individuals can lose a large proportion of their total mass while undergoing treatment, the mass is regained at an average rate of nearly a kilo each month after stopping. "Individuals using such medications should be informed of the potential of rapid rebound weight gain when the therapy ends," cautioned researcher Dr. Susan Jebb. That rate of recovery suggests a return to pre-treatment mass in about 18 months. Analyzing Approaches The analysis, which looked at 37 of studies involving over 9,000 of patients, contrasted the results of the injectable medications with conventional dieting. Researchers emphasize that individuals who shed pounds through diet and exercise generally experience a slower creep back—around 0.1 kg a month—once they finish. Explaining the Rapid Regain Doctors propose the mechanism of the injections accounts for the heightened regain. The injections imitate a body's own chemical called GLP-1, which moderates hunger. "Artificially providing the hormone concentrations far above than normal might result in the system to generate a reduced amount of its own natural hormone, and may also diminish responsiveness to its effects," said Dr. Adam Collins, a nutrition specialist. "Withdrawal of this medication leads to hunger is uncontrolled, making overeating much more probable." An Ongoing Issue? Medical guidelines suggest the injections for people with weight-linked health risks, alongside prescribed diet and exercise modifications. Many experts say that, given the significant potential of relapse, the treatment might need to be long-term. This view is reinforced by drug manufacturers, who say that the findings "underscore the persistent nature of excess weight," akin to managing diseases like diabetes. User Accounts People who have discontinued the medication explain a sudden resurgence of cravings. "It felt as if something flipping and I was suddenly starving," recalled a patient. The struggle is exacerbated if users have not adopted permanent lifestyle or habit changes during therapy. Significant Adoption Figures indicate that millions of people in the UK have tried these injections in the last 12 months, with demand being substantial. Use is higher among females compared to males. The middle-aged demographic shows the highest usage rates. Many access the medications through private prescriptions rather than the NHS. In conclusion, experts emphasize that while these medications are powerful agents for shedding pounds, they are not a permanent solution and maintained weight loss hinges on integrated lifestyle management.